Lanterne Dx, formerly HTL Clinical, is a full-service tissue pathology core organization, including immunohistochemistry (IHC), In Situ Hybridization, Immunofluorescence (IF) and various multiplexing method offerings for medically relevant preclinical and clinical services to the pharmaceutical, biotech, and academic communities. Our CLIA-certified and CAP compliant laboratory and team of experts is comprised of board-certified DVM and MD pathologists, trained histopathologists, scientists and project managers. With our primary focus in oncology, we provide substantiated expertise in clinical trial services and laboratory diagnostics to enable confident, data-driven decisions. Lanterne Dx also provides image analysis, quantification and slide scanning services in support of clinical studies.